Bank of America’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-3,200
Closed -$309K 7357
2020
Q2
$309K Hold
3,200
﹤0.01% 4970
2020
Q1
$150K Hold
3,200
﹤0.01% 5274
2019
Q4
$233K Sell
3,200
-2,800
-47% -$170K ﹤0.01% 5541
2019
Q3
$313K Buy
+6,000
New +$319K ﹤0.01% 5389
2019
Q2
Sell
-55,000
Closed -$2.86M 7553
2019
Q1
$2.86M Buy
+55,000
New +$2.53M ﹤0.01% 3682

Bank of America's MYOK Position: Q4 2020 in Review

Bank of America sold out of MyoKardia, Inc. Common Stock (MYOK) in Q4 2020, closing a stake of 116,998 shares — an estimated $15.9M sold.

Bank of America first reported a position in MYOK in Q4 2015 and held it in 19 quarters. The position peaked at $15.9M in Q3 2020. 0 funds tracked by Wall St. Rank hold MYOK as of Q4 2020.

  • Bank of America reported no remaining MyoKardia, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • Bank of America sold 116,998 MyoKardia, Inc. Common Stock shares in Q4 2020, an estimated $15.9M.
  • Bank of America first reported a position in MyoKardia, Inc. Common Stock in Q4 2015 and held it in 19 quarters.
  • Bank of America's MyoKardia, Inc. Common Stock position peaked at $15.9M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2020.

Based on Bank of America's 13F filing for Q4 2020, filed 10 Feb 2021.